Other Income/Expenses (Net)

-$1.94M

TTM · Period ending: Jun 30, 2026 · USD

FENC Other Income/Expenses (Net)

Latest reported-$1.94Mperiod endingJun 30, 2026

FENC TTM Other Income/Expenses (Net) ($4.30M → -$1.94M)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

FENC other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Fennec Pharmaceuticals Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2026	-1,940,000
Mar 31, 2026	-2,638,000
Dec 31, 2025	-3,302,000
Sep 30, 2025	-1,862,000
Jun 30, 2025	-1,937,000
Mar 31, 2025	-2,031,000
Dec 31, 2024	-2,593,000
Sep 30, 2024	-2,796,000
Jun 30, 2024	-3,134,000
Mar 31, 2024	-3,398,000
Dec 31, 2023	-3,274,000
Sep 30, 2023	-3,132,000
Jun 30, 2023	-2,472,000
Mar 31, 2023	-1,757,000
Dec 31, 2022	-1,125,000
Sep 30, 2022	-623,000
Jun 30, 2022	-445,000
Mar 31, 2022	-463,000
Dec 31, 2021	-123,000
Sep 30, 2021	205,000
Jun 30, 2021	-124,000
Mar 31, 2021	-43,000
Dec 31, 2020	-224,000
Sep 30, 2020	-289,000
Jun 30, 2020	106,000
Mar 31, 2020	189,000
Dec 31, 2019	234,000
Sep 30, 2019	312,000
Jun 30, 2019	357,000
Mar 31, 2019	352,000
Dec 31, 2018	521,000
Sep 30, 2018	625,000
Jun 30, 2018	360,000
Mar 31, 2018	163,000
Dec 31, 2017	-95,000
Sep 30, 2017	-317,000
Jun 30, 2017	-89,000
Mar 31, 2017	13,000
Dec 31, 2016	82,000
Sep 30, 2016	90,000
Jun 30, 2016	243,000
Mar 31, 2016	636,000
Dec 31, 2015	1,231,000
Sep 30, 2015	3,399,000
Jun 30, 2015	4,183,000
Mar 31, 2015	3,987,000
Dec 31, 2014	701,000
Sep 30, 2014	49,000
Jun 30, 2014	-2,665,000
Mar 31, 2014	4,689,000
Dec 31, 2013	3,775,000
Sep 30, 2013	3,371,000
Jun 30, 2013	4,952,000
Mar 31, 2013	-1,934,000
Dec 31, 2012	4,968,000
Sep 30, 2012	8,256,000
Jun 30, 2012	6,190,000
Mar 31, 2012	4,622,000
Dec 31, 2011	6,981,000
Sep 30, 2011	3,386,000
Jun 30, 2011	8,197,000
Mar 31, 2011	9,053,000
Dec 31, 2010	3,363,000
Sep 30, 2010	2,510,000
Jun 30, 2010	-27,000
Mar 31, 2010	998,000
Dec 31, 2009	2,950,000
Sep 30, 2009	5,627,000
Jun 30, 2009	8,852,000
Mar 31, 2009	7,960,000
Dec 31, 2008	10,444,000
Sep 30, 2008	10,984,000
Jun 30, 2008	11,141,000
Mar 31, 2008	11,332,000
Dec 31, 2007	11,011,000
Sep 30, 2007	5,880,003
Jun 30, 2007	2,001,036
Mar 31, 2007	1,866,036
Dec 31, 2006	-2,662,896
Sep 30, 2006	-4,166,885
Jun 30, 2006	-3,595,926
Mar 31, 2006	-3,651,923
Dec 31, 2005	-3,188,991
Sep 30, 2005	-4,481,005
Jun 30, 2005	-4,555,997
Mar 31, 2005	-18,066,950
Dec 31, 2004	-12,788,106
Sep 30, 2004	-3,548,015
Jun 30, 2004	-3,773,529
Mar 31, 2004	1,019,545
Dec 31, 2003	-518,626
Sep 30, 2003	-4,987,608
Jun 30, 2003	-3,689,504
Mar 31, 2003	6,451,879
Dec 31, 2002	3,571,824
Sep 30, 2002	4,242,969
Jun 30, 2002	4,050,708
Mar 31, 2002	5,207,028
Dec 31, 2001	4,297,410
Sep 30, 2001	4,160,981